Press Release – New York, NY – April 19, 2022 – Sichenzia Ross Ference LLP announced today that it represented Sharps Technology, Inc. (Nasdaq: STSS and STSSW), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, in its initial public offering of 3,750,000 units at a public offering price of $4.25 per unit, each consisting of one share of common stock and two warrants to purchase one share of common stock. The gross proceeds from the offering were approximately $16 million, before deducting underwriting discounts, commissions and offering expenses.
The Sichenzia Ross Ference LLP team was led by partners Arthur Marcus and Jeff Cahlon, and associate Michael Blane.
[starbox id=1]
